A Study to Examine the Value of Broad Agnostic Next Generation Sequencing (NGS) Panel Testing Versus Reimbursed Organ-directed NGS: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Center

NCT04641676 · clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
1000
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

The Belgian Society of Medical Oncology

Collaborators